WestGene logo — Pioneering the future of mRNA therapeutics and adjuvants thr...

WestGene

Pioneering the future of mRNA therapeutics and adjuvants through innovative research, development, and manufacturing.

Founded 2021 1 employees Series A Total: $300.00M Biopharma, Health and Wellness +1

General Information

Company Name WestGene
Founded Year 2021
Employees 1
Industries Biopharma, Health and Wellness, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with WestGene. To contact WestGene, visit westgenepharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does WestGene compare?

A PDF of WestGene and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting WestGene soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About WestGene

WestGene is a biopharmaceutical startup, founded in 2021, that is pioneering the future of mRNA therapeutics and adjuvants through innovative research, development, and manufacturing. The company's mission is to focus on the research and development, manufacturing, and sales of mRNA therapeutics and adjuvants in the biopharma and pharmaceutical industries. The most recent milestone for WestGene is the CNY300.00M Series A investment on 20 June 2023, which was led by 盈科创新资产管理有限公司, Huaxin Capital, and Sichuan Huiyuan. This substantial investment signals confidence in WestGene's potential and demonstrates strong support from prominent investors in the biopharmaceutical sector. With this backing, WestGene is well-positioned to continue its groundbreaking work in the field of mRNA therapeutics and adjuvants.

Business keywords: mRNA therapeutics, adjuvants, high-tech enterprise, biopharma, pharmaceuticals

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A CNY300.00M 3
盈科创新资产管理有限公司, Huaxin Capital +1
20 Jun 2023

WestGene Alternatives & Competitors

View All Alternatives
WestGene vs

Developing novel mRNA-based therapeutics

Seed
11 employees
Biotechnology, Health Care
WestGene vs
Moderna
Moderna United States

Our mission is to deliver the greatest possible impact to people through mRNA medicines.

Grant
6245 employees
Biotechnology, Health Care
WestGene vs

Pioneering biological therapeutics to cure difficult diseases and enhance human health through innov...

Venture round
Biotechnology, Health and Wellness

FAQ About WestGene

Pioneering the future of mRNA therapeutics and adjuvants through innovative research, development, and manufacturing.
WestGene was founded in 2021.
WestGene operates in Biopharma, Health and Wellness and Pharmaceutical. Its work centres on mRNA therapeutics, adjuvants, high-tech enterprise and biopharma.
WestGene has approximately 1 employees.
WestGene has completed 1 funding round, raising a total of $300.00M. The latest funding stage is Series A.
Top alternatives and competitors to WestGene include Pantherna Therapeutics GmbH, Moderna, Encuragen, Innogen Pharmaceutical, CoJourney. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
WestGene and Pantherna Therapeutics GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for WestGene, https://bouncewatch.com/company/westgene, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes